Edge Therapeutics, Inc. Development Agreements
2 Contracts & Agreements
- Amended and Restated Master Formulation Development Agreement by and between the Company and Oakwood Laboratories LLC, dated as of June 30, 2017 (Filed With SEC on August 1, 2017)
- Master Formulation Development Agreement by and between the Company and Oakwood Laboratories LLC, dated as of March 12, 2015 (Filed With SEC on March 8, 2016)